Evan L. Fogel

Evan L. Fogel

Auto-generated profile, based on publicly available information

Evan L. Fogel

Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2002 in Endoscopy
Verified
Journal Article
Closed access
EFE. L. Fogel
E. L. Fogel
DED. Eversman
D. Eversman
PJP. Jamidar
P. Jamidar
SSS. Sherman
S. Sherman
GLG. A. Lehman
G. A. Lehman
Background and Study Aims: Patients with suspected or documented sphincter of Oddi dysfunction (SOD) who undergo standard biliary sphincterotomy have high rates of post-procedure pancreatitis. Approximately 75 % of such patients have elevated basal pressures of the pancreatic sphincter. Biliary sphincterotomy (BES) on its own leaves the pancreatic sphincter unablated and may cause transient edema which aggravates the increase in pancreatic sphincter pressure. Combined pancreaticobiliary therapy (PBR), using pancreatic stenting in addition to sphincterotomy may therefore be safer. Patients and Methods: The endoscopic retrograde cholangiopancreatography (ERCP) database was queried for patients with successful double-duct sphincter of Oddi manometry (SOM) who underwent BES alone or PBR between 1994 and 1997. The endoscopist had decided on the technique to be used. From 1995 to 1997 there was a general trend to do PBR. Pancreatitis was defined according to established criteria. Results: The post-ERCP pancreatitis rate among all 436 SOD patients was 19.7 %, while 256 patients with normal SOM results had a pancreatitis rate of 12.9 %. The use of combined PBR was associated with a lower frequency of pancreatitis compared with BES alone (needle-knife over pancreatic duct stent, 14/131 patients, 10.7 %; pull-type pancreaticobiliary sphincterotomy plus pancreatic stent, 15/78 patients, 19.2 %; BES alone, 52/184 patients, 28.3 %). Episodes of moderate and severe pancreatitis were seen more frequently in the BES group. Conclusion: In SOD patients, post-ERCP pancreatitis rates remain high, but have improved with the addition of combined pancreaticobiliary sphincter therapy.

1 April 2017 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
EFEvan L Fogel
Evan L Fogel
SSSafi Shahda
Safi Shahda
KSKumar Sandrasegaran
Kumar Sandrasegaran
JDJohn DeWitt
John DeWitt
JEJeffrey J Easler
Jeffrey J Easler
SSStuart Sherman
Stuart Sherman
Ns. The areas of active research investigation and where our knowledge is limited are emphasized....

9 January 2014 in New England Journal of Medicine
Verified
Journal Article
Closed access
EFEvan L. Fogel
Evan L. Fogel
SSStuart Sherman
Stuart Sherman
A 74-year-old man is admitted to the hospital with acute gallstone pancreatitis without evidence of coexisting ascending cholangitis or biliary obstruction. Conservative treatment is recommended, with the option of removing the obstructing stone if his condition worsens.


8 October 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
SDShatovisha Dey
Shatovisha Dey
LULata M. Udari
Lata M. Udari
PRPrimavera RiveraHernandez
Primavera RiveraHernandez
JKJason J. Kwon
Jason J. Kwon
BWBrandon Willis
Brandon Willis
JKJanaiah Kota
Janaiah Kota
MicroRNA-29 (miR-29) is a critical regulator of fibroinflammatory processes in human diseases. In this study, we found a decrease in miR-29a in experimental and human chronic pancreatitis, leading us to investigate the regulatory role of the miR-29a/b1 cluster in acute pancreatitis (AP) utilizing a conditional miR-29a/b1–KO mouse model. miR-29a/b1-sufficient (WT) and -deficient (KO) mice were administered supramaximal caerulein to induce AP and characterized at different time points, utilizing an array of IHC and biochemical analyses for AP parameters. In caerulein-induced WT mice, miR-29a remained dramatically downregulated at injury. Despite high-inflammatory milieu, fibrosis, and parenchymal disarray in the WT mice during early AP, the pancreata fully restored during recovery. miR-29a/b1–KO mice showed significantly greater inflammation, lymphocyte infiltration, macrophage polarization, and ECM deposition, continuing until late recovery with persistent parenchymal disorganization. The increased pancreatic fibrosis was accompanied by enhanced TGFβ1 coupled with persistent αSMA + PSC activation. Additionally, these mice exhibited higher circulating IL-6 and inflammation in lung parenchyma. Together, this collection of studies indicates that depletion of miR-29a/b1 cluster impacts the fibroinflammatory mechanisms of AP, resulting in (a) aggravated pathogenesis and (b) delayed recovery from the disease, suggesting a protective role of the molecule against AP.

1 February 2020 in The Lancet Gastroenterology & Hepatology
Verified
Journal Article
Closed access
EFEvan L Fogel
Evan L Fogel
GLGlen A Lehman
Glen A Lehman
PTPaul Tarnasky
Paul Tarnasky
GCGregory A Cote
Gregory A Cote
SSSuzette E Schmidt
Suzette E Schmidt
BEB Joseph Elmunzer
B Joseph Elmunzer